Clinical Trial Update: Low-dose Atropine for Myopia Control in Children [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating low-dose atropine to slow progression of myopia in children and is currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia
• Progressive Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: University Eye Hospital, Freiburg | Conditions: Myopia, Progressive | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING